PHARMACEUTICAL COMBINATION FOR TREATING AND/OR PREVENTING DISORDERS RELATED TO OVERWEIGHT AND/OR OBESITY, AND BASED METHOD OF TREATING Russian patent published in 2015 - IPC A61K31/00 A61P3/04 A61K31/717 A61K31/155 

FIELD: medicine.

SUBSTANCE: treating and/or preventing disorders related to overweight and/or obesity, and to methods for preventing or treating disorders related to overweight and/or obesity, including diabetes mellitus is ensured by using a pharmaceutical combination, which contains metformin or its salts, sibutramine or its salts, as well as microcrystalline cellulose in a daily dose as ingredients: sibutramine or its salts 4-17 mg; metformin or its salts 800-2,700 mg; microcrystalline cellulose (25-153.4), or (153.6-158.4), or (158.6-500) mg. The combined use of metformin, sibutramine and microcrystalline cellulose in the declared relations exhibits a synergetic effect, which enables increasing their therapeutic action.

EFFECT: preventive protection and optimisation of treating the patients with overweight or obesity, including type II diabetes mellitus or metabolic syndrome.

6 cl, 2 tbl